PanTher Therapeutics: Funding, Investors & Team (Oct 2026)
PanTher Therapeutics is on a mission to revolutionize cancer care with a proprietary treatment platform designed to enhance therapeutic response with minimal side effects. PanTher’s highly adaptable platform empowers oncologists to treat patients with life-threatening cancer by unlocking a drug’s full potential through direct, sustained treatment at the tumor site. This distinctive targeting capability uniquely positions PanTher to take on the deadliest and most difficult to treat cancers with a lead investigational candidate in pancreatic cancer.
PanTher Therapeutics has raised $14.2M across 2 funding rounds on record, the most recent an undisclosed round announced in Jun 2023.
PanTher Therapeutics Company Profile and Key Stats
Latest funding round on record: Jun 2023.
PanTher Therapeutics Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
PanTher Therapeutics raised $14.2M in a Grant announced in Aug 2022.
10 months later, an undisclosed round was announced in Jun 2023 with no disclosed amount.
PanTher Therapeutics Founders and Leadership Team
Contact details for the PanTher Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →PanTher Therapeutics Funding Compared to Other Biotechnology Startups
Funded Startups Like PanTher Therapeutics in Biotechnology and Cambridge
Companies Similar to PanTher Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
PanTher Therapeutics Funding FAQs
What does PanTher Therapeutics do?
PanTher Therapeutics is on a mission to revolutionize cancer care with a proprietary treatment platform designed to enhance therapeutic response with minimal side effects. PanTher’s highly adaptable platform empowers oncologists to treat patients with life-threatening cancer by unlocking a drug’s full potential through direct, sustained treatment at the tumor site. This distinctive targeting capability uniquely positions PanTher to take on the deadliest and most difficult to treat cancers with a lead investigational candidate in pancreatic cancer.
How much funding has PanTher Therapeutics raised?
PanTher Therapeutics has raised $14.2M across 2 rounds on record.
When did PanTher Therapeutics last raise funding?
PanTher Therapeutics' most recent funding round on record was announced in Jun 2023. The amount was not disclosed.
Who founded PanTher Therapeutics?
FundedIQ lists Laura Indolfi (Founder) at PanTher Therapeutics.
Where is PanTher Therapeutics headquartered?
PanTher Therapeutics is based in Cambridge, Massachusetts, United States.
How many employees does PanTher Therapeutics have?
PanTher Therapeutics is in the 11-50 employee band.
About FundedIQ's PanTher Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for PanTher Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.